Everything below concerns CAS Registry Number. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-31. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic angiotensin IV analog | Peptidomimetic |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in DMSO; limited in water | Typical for small peptides |
| Storage | -20 °C, desiccated | Protect from light and moisture |
| Analytical method | HPLC with UV detection | Purity and identity checks |
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
==== Superficial vein thrombosis ==== SVT is the development of a thrombus in a superficial vein. SVT is not normally clinically significant, but the thrombus can migrate into the deep venous system where it can also give rise to a pulmonary embolism. The main risk factor for SVT in the lower limbs is varicose veins.
A transdermal gel was formulated to address this but plasma concentrations were undetectable. In cats oral tramadol at 6 mg/kg provides equivalent analgesia to intramuscular tramadol at 4 mg/kg. One study comparing tramadol to meperidine found tramadol to be more effective at providing analgesia for cats undergoing ovariohysterectomy. A study looking at treatment of osteoarthritis in geriatric cats found owner-reported improvements but also significant adverse effects. Reported adverse effects of tramadol include: diarrhoea, dysphoria, anorexia, tachycardia, pyrexia, tachypnoea, and increased levels of serotonin leading to agitation. Tramadol has the potential to cause serotonin syndrome when administered alongside serotonin re-uptake inhibitors, monoamine oxidase inhibitors, and tricyclic antidepressants. In horses, tramadol is ineffective by itself. Two studies looking at intravenous tramadol found it provided no thermal or mechanical antinociception, another study looking at oral tramadol for chronic laminitis found it provided minimal analgesia, and another study looking at intraarticular tramadol found it provided no post-operative analgesia following arthroscopy; however, when administered with paracetamol (acetaminophen) tramadol provides short-acting mechanical antinociception and when administered with ketamine oral tramadol provides adequate analgesia for chronic laminitis. Based on this evidence tramadol is not recommended to be provided on its own for analgesia in horses.
Sidibé Aminata Diallo – Malian Academic and politician. former Minister of Basic Education, Literacy, and the National Languages. Mali Diarra Mariam Flantié Diallo - Minister of Communications And Technology, Mali. Souleymane Sidibé (politician) - former Minister of Internal Security and Civil Protection, Foreign Affairs. Ousmane Sy - Politician. former Minister of Territorial Administration and Local Communities; Mali. Sy Kadiatou Sow– Politician and Women's Rights Activist, former governor of Bamako district, the first woman to hold the position in Mali, former minister of foreign affairs, Foreign Malians and African Integration and former Minister of Urban Planning and Habitat. Mali Sangaré Niamoto Ba- Politician, former Ministry of Industry, Investment and Commerce Djibril Sidibé - Malian football player (Born 1982) Djibril Sidibé - French football player of Malian descent (Born 1992) Inna Modja - Singer, songwriter and activist Mamadou Sidibé - Malian musician Moussa Diaby Moctar Ouane- diplomat and politician. Prime minister; former minister of foreign affairs; former ambassador to the United Nations.
Metal-coded tags (MeCAT) method is based on chemical labeling, but rather than using stable isotopes, different lanthanide ions in macrocyclic complexes are used. The quantitative information comes from inductively coupled plasma MS measurements of the labeled peptides. MeCAT can be used in combination with elemental mass spectrometry ICP-MS allowing first-time absolute quantification of the metal bound by MeCAT reagent to a protein or biomolecule. Thus it is possible to determine the absolute amount of protein down to attomole range using external calibration by metal standard solution. It is compatible to protein separation by 2D electrophoresis and chromatography in multiplex experiments. Protein identification and relative quantification can be performed by MALDI-MS/MS and ESI-MS/MS. Mass spectrometers have a limited capacity to detect low-abundance peptides in samples with a high dynamic range. The limited duty cycle of mass spectrometers also restricts the collision rate, resulting in an undersampling. Sample preparation protocols represent sources of experimental bias.
Sources: en.wikipedia.org
Researchers demonstrate an MRI-ML-based approach that can diagnose early Alzheimer's disease with high accuracy and may help identify unknown related changes in the brain. 21 June – The inability to stand on one leg for 10 seconds in mid to later life is linked to a near-doubling in the risk of death from any cause within the next 10 years. 22 June A study concludes that the spread of breast cancer accelerates during sleep. Agilicious, an open-source and open-hardware versatile standardized quadrotor drone, currently tailored toward agility, is released. The world's first quantum computer integrated circuit is demonstrated. 23 June The largest known bacterium, and an organism that has encapsulated DNA despite being identified as a prokaryote and not an eukaryote, with an average length of 10 mm, T. magnifica is reported. A review shows prevalence of long COVID conditions – like mood symptoms, fatigue and sleep disorders – in people age 0–18 years appears to be at ~25% overall. Two studies about aging-related characteristics of long-lived animals like turtles are published, identifying potentially causal protective traits and suggesting many of the species have "slow or negligible senescence" (or aging). Researchers report the controlled growth of diverse foods in the dark via solar energy and electrocatalysis-based artificial photosynthesis as a potential way to increase energy efficiency of food production and reduce its environmental impacts.
=== Development === Insecticides with systemic activity against sucking pests, which are safe to pollinators, are sought after, particularly in view of the partial bans on neonicotinoids. Revised 2023 guidance by registration authorities describes the bee testing that is required for new insecticides to be approved for commercial use.
== Discovery of MiHAs == The significance of MiHAs in an immune response was recognized following transplantation. The recipient developed GVHD despite having a HLA- matched genes at the Major Histocompatibility locus. The experiment raised questions about the possibility of there being MiHAs. More specifically, the first MiHA was discovered when bone marrow transplantation occurred between opposite sexes. The female recipient obtained MHC-matched bone marrow cells but still had active cytotoxic T cells (CD8+). The CD8+ T cells were active and targeted the male bone marrow cells. The male bone marrow cells were found to be presenting a peptide in the MHC groove encoded by a gene on Y chromosome. The peptide was foreign to the female T cells and females lack the Y chromosome and, thus, this MiHA. The MiHAs encoded by the Y chromosome are known as HY antigens.
=== When density varies due to both concentration and temperature === Density variation due to both concentration and temperature is an important field of study in double diffusive convection. If density changes due to both temperature and salinity are taken into account, then some more terms add to the Z-Component of momentum as follows:
Glycerin may generate acrolein when heated at hotter temperatures. Some e-cigarette products had acrolein identified in the e-cigarette vapor, at greatly lower amounts than in cigarette smoke. Several e-cigarette companies have replaced glycerin and propylene glycol with ethylene glycol. In 2014, most e-cigarettes companies began to use water and glycerin as replacement for propylene glycol. In 2015, manufacturers attempted to reduce the formation of formaldehyde and metal substances of the e-cigarette vapor by producing an e-liquid in which propylene glycol is replaced by glycerin. Acetol, beta-nicotyrine, butanal, crotonaldehyde, glyceraldehyde, glycidol, glyoxal, dihydroxyacetone, dioxolanes, lactic acid, methylglyoxal, myosmine, oxalic acid, propanal, pyruvic acid, and vinyl alcohol isomers have been found in the e-cigarette vapor. Hydroxymethylfurfural and furfural have been found in the e-cigarette vapors. The amounts of furans in the e-cigarette vapors were highly associated with power of the e-cigarette and amount of sweetener. The amount of carbonyls vary greatly among different companies and within various samples of the same e-cigarettes. Oxidants and reactive oxygen species (OX/ROS) have been found in the e-cigarette vapor. OX/ROS could react with other chemicals in the e-cigarette vapor because they are highly reactive, causing alterations its chemical composition. E-cigarette vapor have been found to contain OX/ROS at about 100 times less than with cigarette smoke.
Sources: en.wikipedia.org
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.
No major drug regulatory agency has approved dihexa for human use. Published human clinical trials are absent, so its safety and efficacy are not established. It is commonly sold for laboratory research only.
It was developed from research on angiotensin IV analogs and peptide stability. The goal was to find compounds with better brain penetration and metabolic resistance. Early studies used rodent models rather than human participants.
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.